Concepedia

Angela Pasis

AP

Statistics

Publications

3

Citations

86

H-Index

3

Active since

2012

Affiliations

Biogen (United States)(Current)

Angela Pasis is an author at Biogen (United States) specializing in medicine, drug discovery, and medicinal chemistry.

Top concepts

Publications per year

2012–2022

3

Publications

3

Synthesis, SAR and biological evaluation of 1,6-disubstituted-1H-pyrazolo[3,4-d]pyrimidines as dual inhibitors of Aurora kinases and CDK1

Jean‐Yves Le Brazidec, Angela Pasis, Betty Y. Tam et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 39 citations · Full text

, , +9

Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitors

Jean‐Yves Le Brazidec, Angela Pasis, Betty Y. Tam et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 27 citations · Full text

, , +3

BTX-1188, a first-in-class dual degrader of GSPT1 and IKZF1/3, for treatment of acute myeloid leukemia (AML) and solid tumors.

Aparajita H. Chourasia, Hannah Majeski, Angela Pasis et al. · Journal of Clinical Oncology · 2022 · 20 citations

, , +21

1–3 of 3